The changing picture of amyotrophic lateral sclerosis: lessons from European registers

@article{Hardiman2017TheCP,
  title={The changing picture of amyotrophic lateral sclerosis: lessons from European registers},
  author={Orla Hardiman and Ammar Al-Chalabi and Carol Brayne and Ettore Beghi and Leonard H. van den Berg and Adriano Chi{\`o} and Sarah Martin and Giancarlo Logroscino and James Rooney},
  journal={Journal of Neurology, Neurosurgery, and Psychiatry},
  year={2017},
  volume={88},
  pages={557 - 563}
}
Prospective population based-registers of amyotrophic lateral sclerosis (ALS) have operated in Europe for over two decades, and have provided important insights into our understanding of ALS. Here, we review the benefits that population registers have brought to the understanding of the incidence, prevalence, phenotype and genetics of ALS and outline the core operating principles that underlie these registers and facilitate international collaboration. Going forward, we offer lessons learned… 
View on BMJ
kclpure.kcl.ac.uk
79 Citations
Highly Influential Citations
1
Background Citations
18
Methods Citations
2
Results Citations
1

79 Citations

Citation Type

Citation Type

Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Purpose of review The cause of amyotrophic lateral sclerosis (ALS) remains unknown for most of the patients with the disease. Epidemiologic studies can help describe disease burden and examine its…
Multicentre, prospective registry study of amyotrophic lateral sclerosis in mainland China (CHALSR): study protocol
TLDR
The aim of this study was to explore the natural history and clinical features of ALS in mainland China through a multicentre, prospective cohort study, which will both offer a better understanding of ALS and also support the development of a model to study other rare diseases.
The epidemiology and genetics of Amyotrophic lateral sclerosis in China
TLDR
It is suggested that it is necessary to carry out a prospective population-based study and large-scale gene sequencing around China to better define epidemiological and genetic features of Chinese ALS patients.
Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.
TLDR
Data collected by the National ALS Registry are being used to better describe the epidemiology and demographics of ALS in the U.S. to better examine risk factors such as environmental and occupational exposures, and characterize the demographics of those living with the disease.
The epidemiology of amyotrophic lateral sclerosis in Moscow (Russia)
TLDR
The incidence of ALS in the Russian Federation is higher than previously reported but lower than in other countries, and poor diagnostic ascertainment, particularly in women, and the shorter life expectancy of the Russian population are possible explanations.
Amyotrophic lateral sclerosis
TLDR
Clinical and diagnostic approaches as well as scientific advances in the research fields of genetics, disease modelling, biomarkers, and therapeutic strategies are discussed.
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis
TLDR
A flexible design framework is proposed which naturally adapts the trial duration when inaccurate assumptions are made at the design stage such as the enrollment or survival rate and may serve a blueprint for future clinical trials in this population of patients.
Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study
TLDR
ALS patients exhibit aberrant expression of selected mediators of the lectin complement pathway as well as increased activation of the terminal complement pathway, corroborating the notion that the complement system might be involved in the pathophysiology of ALS.
Natural history and clinical features of ALS in Malaysia
TLDR
In this cohort, diagnostic delay and a slow disease progression were significantly associated with better survival in ALS and ethnic variation with Chinese preponderance and more rapid disease progression in patients of Indian descent was found.
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
TLDR
An externally validated model is developed to predict survival without tracheostomy and non-invasive ventilation for more than 23 h per day in European patients with ALS and could be applied to individualised patient management, counselling, and future trial design.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 78 REFERENCES
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
TLDR
The contribution of the various population based registers is outlined, the limitations of the existing datasets are identified and a mechanism to improve the future design and output of descriptive epidemiological studies is proposed.
Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004
TLDR
The annual incidence rate of ALS in Ireland remained stable over this time and median survival of Irish ALS patients was 16.4 months and did not change during the study period.
Amyotrophic lateral sclerosis: Analysis of ALS cases in a predominantly admixed population of Ecuador
TLDR
Investigation in the predominantly admixed population of Ecuador found that ALS incidence in the Ecuadorian hospital population is in accord with rates reported in recent studies for other admixed populations, and lower than that in the United States and Europe.
Incidence of amyotrophic lateral sclerosis in Europe
TLDR
Sex differences in incidence may be explained by the higher incidence of spinal onset ALS among men, and the age related disease pattern suggests that ALS occurs within a susceptible group within the population rather than being a disease of ageing.
Incidence of Amyotrophic Lateral Sclerosis in the Local Health District of Ferrara, Italy, 1964–1998
TLDR
An increase in incidence of ALS in the local health district of Ferrara, northern Italy in the years 1964-1998 seems to be explained mainly by the ageing of the population and the role of environmental factors cannot be excluded.
Geographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study
TLDR
An excess of ALS cases in some postcode districts in south-east England is suggested, suggesting environmental factors that trigger ALS might result in a pattern of geographical clustering of cases.
Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin
TLDR
A systematic review and meta-analysis of the literature concerning differences in phenotype and outcome of ALS that relate to PAO sets the scene for a collaborative study involving a wide international consortium to investigate the link between ancestry, environment, and ALS phenotype.
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
TLDR
It is proposed that multiple decision-making processes within a multidisciplinary setting lead to an enriched set of clinical encounters for the patient and carer that enhances clinical outcome.
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
TLDR
A linear relationship between the log incidence and log age of onset of amyotrophic lateral sclerosis is consistent with a multistage model of disease, and the slope estimate suggests that the disease is a six-step process.
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
TLDR
A systematic review and meta-analysis of population-based data published to date confirms a heterogeneous distribution worldwide of ALS, and sets the scene to sustain a collaborative study involving a wide international consortium to investigate the link between ancestry, environment and ALS incidence.
...
1
2
3
4
5
...